Science and Technology Platforms Applied to Medical Countermeasure (MCM) Development

This contract seeks proposals for research and development projects that advance science and technology platforms applied to medical countermeasure (MCM) development, specifically targeting biodefense, pandemic influenza, and emerging infectious diseases. Managed by the Biomedical Advanced Research and Development Authority (BARDA), the solicitation aims to support projects that accelerate the pipeline and evaluation of candidate vaccines and therapeutics, enhance product safety and manufacturability, repurpose products for novel pathogens, and develop rapid in vitro diagnostic platforms. The funding is intended to bridge the late stages of product development by supporting efforts that are integrated with regulatory activities, focusing on innovations that improve national health security and preparedness. BARDA’s mission under this Broad Agency Announcement is aligned with its Strategic Plan and directives from the Pandemic and All-Hazard Preparedness Act to promote nimble, responsive programs that address both current and emerging biological threats. Multiple awards may be made to projects with strong potential and alignment with BARDA’s Strategic Science and Technology Areas of Interest. The contract emphasizes advanced development at various stages, excluding late-stage development specifically for CBRN and influenza products. This solicitation continues a previous BAA and invites interested parties to contact designated contracting officers for further information, reinforcing BARDA’s commitment to fostering innovative medical countermeasures to enhance national preparedness and response capabilities.